Ghasempour, S.* ; Warner, N.* ; Guan, R.* ; Rodari, M.M.* ; Ivanochko, D.* ; Whittaker Hawkins, R.* ; Marwaha, A.* ; Nowak, J.K.* ; Liang, Y.* ; Mulder, D.J.* ; Stallard, L.* ; Li, M.* ; Yu, D.D.* ; Pluthero, F.G.* ; Batura, V.* ; Zhao, M.* ; Siddiqui, I.* ; Upton, J.E.M.* ; Hulst, J.M.* ; Kahr, W.H.A.* ; Mendoza-Londono, R.* ; Charbit-Henrion, F.* ; Hoefsloot, L.H.* ; Khiat, A.* ; Moreira, D.* ; Trindade, E.* ; Espinheira, M.D.C.* ; Pinto Pais, I.* ; Weerts, M.J.A.* ; Douben, H.* ; Kotlarz, D.M. ; Snapper, S.B.* ; Klein, C.* ; Dowling, J.J.* ; Julien, J.P.* ; Joosten, M.* ; Cerf-Bensussan, N.* ; Freeman, S.A.* ; Parlato, M.* ; van Ham, T.J.* ; Muise, A.M.*
Human ITGAV variants are associated with immune dysregulation, brain abnormalities, and colitis.
J. Exp. Med. 221:e20240546 (2024)
Integrin heterodimers containing an Integrin alpha V subunit are essential for development and play critical roles in cell adhesion and signaling. We identified biallelic variants in the gene coding for Integrin alpha V (ITGAV) in three independent families (two patients and four fetuses) that either caused abnormal mRNA and the loss of functional protein or caused mistargeting of the integrin. This led to eye and brain abnormalities, inflammatory bowel disease, immune dysregulation, and other developmental issues. Mechanistically, the reduction of functional Integrin αV resulted in the dysregulation of several pathways including TGF-β-dependent signaling and αVβ3-regulated immune signaling. These effects were confirmed using immunostaining, RNA sequencing, and functional studies in patient-derived cells. The genetic deletion of itgav in zebrafish recapitulated patient phenotypes including retinal and brain defects and the loss of microglia in early development as well as colitis in juvenile zebrafish with reduced SMAD3 expression and transcriptional regulation. Taken together, the ITGAV variants identified in this report caused a previously unknown human disease characterized by brain and developmental defects in the case of complete loss-of-function and atopy, neurodevelopmental defects, and colitis in cases of incomplete loss-of-function.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
0022-1007
e-ISSN
1540-9538
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 221,
Heft: 12,
Seiten: ,
Artikelnummer: e20240546
Supplement: ,
Reihe
Verlag
Rockefeller University Press
Verlagsort
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Translational Genomics (ITG)
POF Topic(s)
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-506700-001
Förderungen
Lassonde Family Precision IBD Initiative
Canadian Institute for Advanced Research
Canada Research Chair Program
Canada Foundation for Innovation
Ontario Research Foundation
Institut National de la Santé et de la Recherche Médicale
Fondation Princesse Grace de Monaco
Leona M. and Harry B. Helmsley Charitable Trust
CIHR Foundation Grant
Government of Ontario
Hospital for Sick Children
Copyright
Erfassungsdatum
2024-11-20